Picture of Evolus logo

EOLS — Evolus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview

Evolus Inc <EOLS.OQ> expected to post a loss of 3 cents a share - Earnings Preview 
  • Evolus Inc EOLS.OQ EOLS.O is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2026

  • The Newport Beach California-based company is expected to report a 17.6% increase in revenue to $81.603 million from $69.39 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data. (Majority is on Total Revenue Basis)

  • ​LSEG's mean analyst estimate for Evolus Inc is for a loss of 3 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Evolus Inc is $14.00, about 139.7% above its last closing price of $5.84

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2026

-0.12

-0.13

-0.05

Beat

61.5

Dec. 31 2026

0.06

0.05

0.05

Met

0

Sep. 30 2025

-0.17

-0.17

-0.11

Beat

36.2​

Jun. 30 2025

-0.10

-0.11

-0.23

Missed

-113

​​Mar. 31 2025

-0.17

-0.15

-0.15

Met

-3

Dec. 31 2024

0.04

0.04

0.04

Met

5.3​

Sep. 30 2024

-0.09

-0.10

-0.16

Missed

-64.1

Jun. 30 2024

-0.05

-0.05

-0.04

Beat

23.1

This summary was machine generated August 3 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Evolus

See all news